Fundraising FoxBiomotum
Portland, US · Founded 2019 · Delaware corporation · 4 known investors
Find your way into Biomotum
Sign up to see every warm intro you have to Biomotum
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomotum team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.
Founders & leadership
Biomotum was founded in 2019 by Ray Browning and Zach Lerner.
RB
Ray BrowningCEO & Co FounderRay Browning founded Biomotum, a company developing wearable robotic systems for gait rehabilitation. He has background in research and product development across industry and academic settings, with expertise in engineering, human performance, and clinical science.
ZL
Zach LernerCTO & Co FounderAn associate professor of mechanical engineering at Northern Arizona University, where he has held the position since 2022. He completed his PhD at Colorado State University and was a postdoctoral researcher at the National Institutes of Health.
Investors · 4
Elevate Capitallisted by Elevate CapitalPortland · $2M – $25M
How we know: the VCSheet dataset · Not right? Tell us
Portland Seed Fundlisted by Portland Seed FundPortland · $25K
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$860K disclosed across 2 rounds · 2020–2022
▶$200KraisedMar 2022 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedMar 2022 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary L. LernerExecutive Officer, Director
- Raymond C. BrowningExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$660KraisedNov 2020 · 3 investors · Other TechnologyRule 506(b)
▶$660KraisedNov 2020 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- RAYMOND C BROWNINGExecutive Officer, Director, Promoter
- ZACHARY L LERNERExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $660K
- Minimum investment
- $25K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
BioptimusBioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation. It applies machine learning to areas such as computational pathology, genomics, and drug discovery.
Ekso BionicsEkso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Hypershell GlobalHypershell builds wearable exoskeletons that assist walking, hiking, climbing, and cycling by reducing physical exertion and heart rate over long distances and steep terrain. Its products target outdoor adventurers, hikers, and expedition guides, and it is presented as the first exoskeleton to undergo third-party validation of its performance claims.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
German BionicGerman Bionic develops wearable exoskeletons and smart power suits that use AI to assist workers with heavy lifting, prevent posture injuries, and improve workplace safety. The company serves industrial, logistics, healthcare, and airport operations sectors globally.
BioventusBioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures. The company serves healthcare providers and patients seeking clinically effective, cost-efficient alternatives to traditional treatments.
Mammoth BiosciencesMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
Companies working in the same space as Biomotum.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $274.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $298.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Biomotum do?
- Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.
- Who founded Biomotum?
- Biomotum was founded by Ray Browning, Zach Lerner in 2019.
- Who are Biomotum's investors?
- Biomotum's investors include Bronco Ventures, Creative Destruction Lab (CDL), Elevate Capital, Portland Seed Fund.
- How much funding has Biomotum raised?
- Biomotum has disclosed $860K raised across 2 rounds.
- Where is Biomotum headquartered?
- Biomotum is headquartered in Portland, US.